arrow
A

Annarosa Del Mistro

istituto oncologico veneto
H指数:41
被引数:6,185

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Population-Based First Estimates of the Effect of HPV Vaccination in Three Italian Areas Covered by Organised Cervical Screening

基于人群的首个意大利三个地区组织化宫颈癌筛查覆盖地区的HPV疫苗接种效果估计

2026-05-010
PRE
Risk-Based Triage of Women with Persistent HR-HPV Positivity at 12-Month Recall in Cervical Cancer Screening: A Multicenter Retrospective Evaluation of Cytology and Partial HPV Genotyping

基于风险的妇女宫颈癌筛查中12个月随访持续性HR-HPV阳性患者的分层管理:多中心回顾性评估细胞学和部分HPV基因分型

Cancers
IF4.4
2026-01-010
OA
Impact of differentiating between persistent and new infections on colposcopy referral in HPV-positive triage-negative women: results from the NTCC2 study

区分持续感染与新感染对HPV阳性但Triage阴性的女性进行阴道镜转诊的影响:NTCC2研究的结果

2025-11-210
OAAI
Predictive biomarkers for regression in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2: A prospective multicenter study in Italy

宫颈上皮内瘤变2级女性在积极随访中发生消退的预测生物标志物:一项在意大利进行的多中心前瞻性研究

2025-08-300
OAAI
Extended HPV genotyping by the BD Onclarity assay: concordance with screening HPV-DNA assays, triage biomarkers, and histopathology in women from the NTCC2 study

通过BD Onclarity分析进行的扩展HPV基因分型: 与NTCC2研究中女性的筛查hpv-dna分析,分类生物标志物和组织病理学相一致

2025-01-070
PRE
Comparison of HPV-positive triage strategies combining extended genotyping with cytology or p16/ki67 dual staining in the Italian NTCC2 study

在意大利NTCC2研究中,HPV阳性分诊策略结合扩展基因分型与细胞学或p16/ki67双重染色的比较

2024-06-010
OAAI
The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naive tumors with immune checkpoint inhibitors
2022-09-2036
OAAI
Performance of HPV E6/E7 mRNA assay as primary screening test: Results from the NTCC2 trial
2022-06-0711
PRE
p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women
2020-08-0345
OAAI